Clinical trial
Preventing Antibiotic-Associated DiarRhea Using Erceflora
NCT00447161 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00447161 |
|---|---|
| Title | Preventing Antibiotic-Associated DiarRhea Using Erceflora |
| Official title | Bacillus Clausii in Preventing Antibiotic-Associated Diarrhea Among Filipino Infant and Children: A Multi-Center, Randomized, Open-Label Controlled (Treatment vs No Treatment) Clinical Trial of Efficacy and Safety |
| Acronym | PADRE |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diarrhea, Infantile |
| Intervention type | Drug |
| Interventions | Bacillus Clausii Multi ATB Resist, Placebo |
| Enrollment | 323 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2007 |
| First posted | Mar 14, 2007 |
| Last update posted | Sep 5, 2008 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: